ML277

CAS No. 1401242-74-7

ML277( CID-53347902 )

Catalog No. M23558 CAS No. 1401242-74-7

ML277 was identified as a potent activator of KCNQ1 channels (EC(50)=260 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 77 In Stock
5MG 67 In Stock
10MG 112 In Stock
25MG 202 In Stock
50MG 299 In Stock
100MG 449 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ML277
  • Note
    Research use only, not for human use.
  • Brief Description
    ML277 was identified as a potent activator of KCNQ1 channels (EC(50)=260 nM).
  • Description
    ML277 was identified as a potent activator of KCNQ1 channels (EC(50)=260 nM).
  • In Vitro
    ML277 (1 μM) increases the amplitude of KCNQ1 whole-cell and single-channel currents.
  • In Vivo
    ——
  • Synonyms
    CID-53347902
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Potassium Channel
  • Recptor
    KCNQ1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1401242-74-7
  • Formula Weight
    471.6
  • Molecular Formula
    C23H25N3O4S2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:≥60 mg/mL (127.23mM)
  • SMILES
    O=C([C@@H]1N(S(=O)(C2=CC=C(C)C=C2)=O)CCCC1)NC3=NC(C4=CC=C(OC)C=C4)=CS3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Mattmann ME, Yu H, Lin Z, et al. Identification of (R)-N-(4-(4-methoxyphenyl)thiazol-2-yl)-1-tosylpiperidine-2-carboxamide, ML277, as a novel, potent and selective K(v)7.1 (KCNQ1) potassium channel activator. Bioorg Med Chem Lett. 2012;22(18):5936-5941. doi:10.1016/j.bmcl.2012.07.060
molnova catalog
related products
  • Hexachlorophene

    Hexachlorophene(Hexachlorofen) is a potent KCNQ1/KCNE1 potassium channel activator with EC50 of 4.61 ± 1.29 μM; also is an inhibitor of Wnt/beta-catenin signaling.

  • ML402

    ML402 is an activator of TREK-1 and TREK-2 with EC50s of 13.7 μM and 5.9 μM.

  • Almitrine dimesylate

    Almitrine dimesylate inhibits selectively the Ca2+-dependent K+ channel and that in rat chemoreceptor cellsused in the treatment of hypoxemic chronic lung diseases.